Exemestane: One part of the chemopreventive spectrum for ER-positive breast cancer
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference86 articles.
1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010
2. Potential role of tamoxifen in prevention of breast cancer;Nayfield;J Natl Cancer Inst,1991
3. Breast cancer prevention trials: large and small trials;Arun;Semin Oncol,2010
4. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study;Fisher;J Natl Cancer Inst,1998
5. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial;Powles;Lancet,1998
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association between obesity and risk of fracture, bone mineral density and bone quality in adults: A systematic review and meta-analysis;PLOS ONE;2021-06-08
2. Ribociclib for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer;Future Oncology;2017-10
3. Worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in midlife postmenopausal hormone users;The Breast;2017-08
4. Triggering of Suicidal Erythrocyte Death by Exemestane;Cellular Physiology and Biochemistry;2017
5. Prolonged response to exemestane following multiple surgical resections and hormonal therapies in a patient with recurrent endometrial stromal sarcoma;Gynecologic Oncology Reports;2016-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3